Tevogen Bio (TVGN) Stock Analysis
NASDAQHealthcareBiotechnology
What Tevogen Bio does
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.
Key metrics
ETFs linked to TVGN
Broad-market and Healthcare sector ETFs an investor holding Tevogen Bio is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how TVGN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze TVGN in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Tevogen Bio?
- Tevogen Bio trades under the ticker TVGN on NASDAQ.
- Which exchange is TVGN listed on?
- TVGN is listed on NASDAQ.
- What sector does Tevogen Bio operate in?
- Tevogen Bio is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze TVGN in a portfolio?
- PortView shows TVGN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.